These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Use of thalidomide in HIV infection. Taiwo BO AIDS Read; 2001 Oct; 11(10):511-3, 518-9, 523-4. PubMed ID: 11708084 [TBL] [Abstract][Full Text] [Related]
5. Thalidomide for recurrent aphthous ulcerations. Shetty K HIV Clin; 2003; 15(3):1, 4-6. PubMed ID: 12945529 [No Abstract] [Full Text] [Related]
7. Thalidomide as an emerging immunotherapeutic agent. Marriott JB; Muller G; Dalgleish AG Immunol Today; 1999 Dec; 20(12):538-40. PubMed ID: 10562702 [No Abstract] [Full Text] [Related]
8. Thalidomide for wasting syndrome: progress toward compromise. James JS AIDS Treat News; 1995 Nov; (no 234):1-5. PubMed ID: 11363041 [TBL] [Abstract][Full Text] [Related]
9. Thalidomide makes a comeback. Dodd-Butera T; Broderick M RN; 2003 May; 66(5):32-5; quiz 36. PubMed ID: 12778690 [No Abstract] [Full Text] [Related]
10. Thalidomide and HIV: several possible uses. Smith D AIDS Treat News; 1995 Apr; (no 221):1-4. PubMed ID: 11362402 [TBL] [Abstract][Full Text] [Related]
12. Thalidomide: a re-look. Grover JK; Vats V; Gopalakrishna R; Ramam M Natl Med J India; 2000; 13(3):132-41. PubMed ID: 11558112 [TBL] [Abstract][Full Text] [Related]
13. Thalidomide in leprosy and some dermatological conditions--a review. Parikh DA; Maniar JK; Ganapati R Indian J Lepr; 1985; 57(4):862-7. PubMed ID: 3915010 [No Abstract] [Full Text] [Related]
14. Thalidomide therapy for inflammatory dermatoses. Grosshans E; Illy G Int J Dermatol; 1984 Nov; 23(9):598-602. PubMed ID: 6097551 [No Abstract] [Full Text] [Related]